Typhoid Fever and Invasive Nontyphoid Salmonellosis, Malawi and South Africa by Feasey, Nicholas A. et al.





Nicholas A. Feasey, Brett N. Archer, 
Robert S. Heyderman, Arvinda Sooka, 
Brigitte Dennis, Melita A. Gordon, 
and Karen H. Keddy
To determine the prevalence of invasive nontyphoid 
salmonellosis and typhoid fever in Malawi and South Africa, 
we compared case frequency and patient age distribution. 
Invasive nontyphoid salmonellosis showed a clear bimod-
al age distribution; the infection developed in women at a 
younger age than in men. Case frequency for typhoid fever 
was lower than for salmonellosis. 
I
nvasive nontyphoid salmonellosis (iNTS) was ﬁ  rst de-
scribed as an AIDS-related illness in Africa and the 
United States in the 1980s. Although incidence in in-
dustrialized countries declined, nontyphoid Salmonella 
(NTS) spp. serovars (predominantly S. enterica serovars 
Typhimurium and Enteritidis) remain a common cause of 
bloodstream and focal infection in sub-Saharan Africa for 
adults with HIV infection and children with HIV, malaria, 
and malnutrition. iNTS has a strong seasonal pattern in 
adults and children. In addition, epidemics of iNTS have 
been described as associated with the emergence of multi-
drug resistance in Malawi (1). Similarly, multidrug resis-
tance is well recognized in iNTS in South Africa (www.
nicd.ac.za/pubs/survbull/2010/CommDisBullMay10_
Vol0802.pdf). Death rates are 20%–25% among adults 
and children (1). In sub-Saharan Africa, transmission is 
thought most likely to be between humans, and no food 
or animal source has been found, although epidemiologic 
data remain sparse (2).
In comparison to iNTS, S. enterica serovar Typhi is 
a highly adapted, invasive, human-restricted pathogen that 
in the 19th century caused considerable illness and death 
in the United States and Europe but now has the greatest 
impact in developing countries. In sub-Saharan Africa, per-
haps surprisingly, typhoid fever is not associated with HIV 
among adults (3).
Regional data on the demography and prevalence of 
both iNTS and S. Typhi for sub-Saharan Africa are incom-
plete (4). Estimates of incidence of iNTS among children, 
175–388/100,000 (5–7), and among adult HIV-prevalent 
cohorts, 2,000–8,500/100,000 (8–10), have been made 
separately, in different locations, giving no overall demo-
graphic picture. Estimates of the incidence of typhoid fever 
have relied on limited available data from sub-Saharan Af-
rica (11). Although typhoid is usually regarded as an illness 
of school-age (>5 years of age) children and young adults, 
there is considerable heterogeneity; some sites in Asia 
report high incidences of typhoid fever among children 
<5 years of age (12). We compared case frequency and 
patient age distribution for the predominant types of inva-
sive salmonellosis among febrile patients of all ages treated 
at our 2 centers in 2 regions in sub-Saharan Africa, Malawi 
and South Africa, before 2004.
The Study
In Malawi, Queen Elizabeth Central Hospital is the 
government-funded hospital for Blantyre District, serving 
≈1 million persons. From January 1998 through Decem-
ber 2004, persons from the community who came to the 
hospital with fever (adults >14 years, axillary temperature 
>37°C; and children <14 years and >1 month, tempera-
ture >37.5°C, and negative malaria test result) had venous 
blood taken for routine culture, as previously described 
(1). During 1998–2000, a manual culture system was used. 
From December 2000 onward, the same volume of blood 
was cultured by using the BacT/Alert 3D automated system 
(bioMérieux, Marcy l’Étoile, France). All isolates were 
identiﬁ  ed by using standard diagnostic techniques. Out-
breaks caused by individual NTS serovars were observed 
during this period, occurred simultaneously among adults 
and children, and showed an identical age distribution to 
baseline data (1).
In South Africa, active laboratory-based surveillance 
for  Salmonella spp. was introduced nationally in 2003. 
Data from January 2003 through December 2004 were col-
lected by the Enteric Disease Reference Unit, the national 
reference center representing data from >250 diagnos-
tic laboratories across South Africa, serving ≈46 million 
persons (www.nhls.ac.za). Samples from normally sterile 
sites (bloodstream, cerebrospinal ﬂ  uid, pleural ﬂ  uid) from 
patients admitted to hospitals in South Africa were col-
lected according to the clinician’s judgment, and isolates 
were submitted to the local diagnostic laboratory, where 
they were identiﬁ   ed by using standard diagnostic tech-
niques before being sent to Enteric Disease Reference Unit 
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for conﬁ  rmation of identiﬁ  cation and serotype. No major 
outbreaks of typhoid fever or iNTS were observed during 
this period.
Conclusions
In South Africa during 2003 and 2004, 1,318 cases of 
iNTS were microbiologically conﬁ  rmed (67% S. Typhimu-
rium, 10% S. Enteritidis, 7% S. Isangi, and 6% S. Dublin), 
and 105 cases of S. Typhi were identiﬁ  ed under surveil-
lance that included demographic data. In Malawi during 
1998–2004, 62,778 blood samples were taken, of which 
10,628 yielded pathogens. Information included 4,956 cas-
es of iNTS (75% S. Typhimurium, 21% S. Enteritidis), for 
which demographic data were available for 4,044, and 105 
cases of S. Typhi bacteremia, for which demographic data 
were available for 75. 
Age distribution of patients with of iNTS and typhoid 
fever in Malawi and South Africa are shown in Figure 1. 
Despite the potential differences in sampling and surveil-
lance intensity between sites, the data show a similar pat-
tern of age distribution for iNTS at both sites, with a clear 
bimodal distribution. A peak was seen during the ﬁ  rst 2 
years of life, which rapidly declined thereafter until a sec-
ond peak at ≈30 years. This age distribution was the same 
for all individual NTS serovars apart from S. Isangi and 
reﬂ  ects the well-described risk factors for NTS infection: 
malaria, malnutrition, and HIV among children, and HIV 
among adults. A relative paucity of iNTS in the ﬁ  rst few 
months of life has been reported from the Malawi center 
(13). We note that 32% (425/1,318) compared with 54% 
(2176/4044) of iNTS cases were in children <15 years 
of age for South Africa and Malawi, respectively. It is, 
however, not possible to say whether this observed dif-
ference may be explained by sampling bias, differences 
in population demographics, or iNTS speciﬁ  c risk factors 
in the 2 countries. Notably, patients from whom S. Isangi 
was isolated in South Africa were signiﬁ  cantly younger 
(median age 5 years; p<0.001) than patients infected with 
other serovars.
There was a signiﬁ  cant gender difference in the age 
at which adults acquire iNTS (Figure 2). iNTS occurred in 
women at a younger age than men in South Africa (median 
age 30 years for women vs. 35 years for men; p<0.001) and 
Malawi (median age 33 years for women vs. 37 years for 
men; p<0.001). The principal risk factor for iNTS among 
adults is HIV (3), and this ﬁ  nding is consistent with the 
observation that women acquire HIV infection at a younger 
age than men. The HIV prevalence in those 15–24 years 
of age is 3× greater among women than men across sub-
Saharan Africa. In South Africa the difference is even more 
marked, and HIV prevalence peaks in women 25–29 years 
of age and in men 30–34 years of age (14) 
The relative frequency of iNTS cases detected by both 
centers was much higher than that of S. Typhi, which sug-
gests a substantially higher number of cases. However, the 
different sampling protocols do not permit comment on ab-
solute incidence rates. 
Typhoid fever patients showed a markedly contrasting 
age distribution from that seen in iNTS, affecting mainly 
school-age children and younger adults, but differed slight-
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Figure 1. Age and gender distribution of patients with invasive nontyphoid Salmonella spp. infections in A) South Africa, 2003–2004, and 
B) Blantyre, Malawi, 1998–2004; and age and gender distribution of patients with Salmonella enterica serovar Typhi infection in C) South 
Africa, 2003–2004, and D) Blantyre, Malawi, 1998–2004.ly between the 2 sites. In Malawi, 15 of 75 typhoid cases 
were in preschool-age children, compared with only 5 of 
105 of cases in South Africa. Again, the reasons for this 
cannot be determined. 
It is noteworthy that the relative case frequencies and 
age distributions of iNTS and typhoid are so contrasting. 
Unlike in industrialized countries, NTS in sub-Saharan 
Africa is thought to be transmitted person to person, and 
a unique pathovar, Salmonella Typhimurium ST313, has 
emerged that shows genomic degradation similar to that 
seen in the human-restricted S. Typhi (15). Despite this evi-
dence of convergent evolution, these data strongly suggest 
that the epidemiology and transmission routes of S. Typhi 
and NTS may be distinct. It remains to be seen what effects 
the wide availability of antiretroviral drugs or enhanced 
malaria eradication programs in sub-Saharan Africa will 
have on the demography of iNTS. 
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